Avantor, Inc. (NYSE:AVTR – Get Free Report) has been assigned an average recommendation of “Hold” from the fifteen research firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, eleven have given a hold recommendation and three have given a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $13.60.
A number of research firms have recently commented on AVTR. Jefferies Financial Group cut Avantor to an “underperform” rating in a research report on Wednesday, December 17th. Raymond James Financial cut Avantor from an “outperform” rating to a “market perform” rating in a research note on Tuesday, November 4th. Zacks Research raised Avantor from a “strong sell” rating to a “hold” rating in a report on Monday, December 29th. UBS Group set a $12.00 target price on shares of Avantor in a report on Thursday, October 30th. Finally, Robert W. Baird increased their price target on shares of Avantor from $15.00 to $17.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th.
Get Our Latest Stock Report on Avantor
Avantor Trading Down 3.2%
Insider Buying and Selling at Avantor
In related news, Director Sanjeev K. Mehra purchased 350,000 shares of the stock in a transaction that occurred on Friday, December 5th. The shares were purchased at an average price of $11.09 per share, with a total value of $3,881,500.00. Following the completion of the acquisition, the director directly owned 350,000 shares in the company, valued at $3,881,500. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.20% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the stock. EverSource Wealth Advisors LLC raised its stake in shares of Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after purchasing an additional 1,189 shares during the last quarter. Strategic Wealth Investment Group LLC acquired a new position in Avantor in the 2nd quarter valued at $32,000. FNY Investment Advisers LLC purchased a new position in Avantor during the 2nd quarter worth $36,000. Private Trust Co. NA lifted its stake in shares of Avantor by 46.2% in the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock worth $32,000 after acquiring an additional 875 shares during the period. Finally, Osaic Holdings Inc. boosted its holdings in shares of Avantor by 60.9% in the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after acquiring an additional 1,064 shares in the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.
About Avantor
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Featured Articles
- Five stocks we like better than Avantor
- Your Bank Account Is No Longer Safe
- When to buy gold (mathematically)
- Nervous about the stock market? Read this
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
